Clinical trials
Recruiting Multiple Myeloma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 3 |
| 2025 | 14 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Myeloma Network B.V. | 4 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 4 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 3 |
| Janssen Research & Development, LLC | 3 |
| Pfizer | 3 |
| AstraZeneca | 2 |
| Azienda Ospedaliero-Universitaria di Parma | 2 |
| Azienda USL Reggio Emilia - IRCCS | 2 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 2 |
| Takeda | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 45 |
| Neoplasms, Plasma Cell | 3 |
| Recurrence | 3 |
| Smoldering Multiple Myeloma | 3 |
| Hematologic Neoplasms | 2 |
| Immunoglobulin Light-chain Amyloidosis | 2 |
| Lymphoma | 2 |
| Monoclonal Gammopathy of Undetermined Significance | 2 |
| Myeloproliferative Disorders | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.